The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis
PSODEEP1
Questionnaire on Self-reported Experience of Koebner and Deep-Koebner Phenomenon in Patients With Psoriasis and Psoriatic Arthritis.
1 other identifier
observational
3,064
1 country
1
Brief Summary
PSODEEP 1 is a descriptive digital interview study where we intend to include at least 900 individuals. Individuals with known psoriasis or known psoriatic arthritis will access the digital interview via a QR code distributed via their rheumatology or dermatology department using their smartphones. Data on answers results are stored digitally and can be accessed parallel to recruitment. Questions focus on following fields (all self reported): background information (age/sex), disease duration, disease course/fluctuation, disease diagnosis as given by MD, disease treatment, disease severity, disease classification, disease triggers, screening of psoriatic arthritis (questions derived from PEST questionnaire), Koebner occurence, variability in Koebner over time, deep-Koebner occurence and variability in Deep-Koebner over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2022
CompletedStudy Start
First participant enrolled
October 19, 2022
CompletedFirst Posted
Study publicly available on registry
October 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2024
CompletedDecember 4, 2024
December 1, 2024
1.3 years
October 15, 2022
December 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Koebner
Occurence of Self-Reported Koebner phenomena. Self-reported in multiple choice questionnaire "Has your skin psoriasis ever developed at the site of a skin injury, such as a scrape or a burn?" YES/NO/DO NOT KNOW. Ordinal data.
Through study completion, estimated to 12 months.
Trauma induced Deep-Koebner
Occurence of Self-Reported trauma induced Deep-Koebner phenomena in patients with with psoriasis arthritis. Questionnaire, self-reported, multiple choice "Have you ever developed psoriatic arthritis in a joint after injury, e.g. after a fall or sprain? " YES/NO/DO NOT KNOW. Ordinal data.
Through study completion, estimated to 12 months.
Secondary Outcomes (2)
Variation in Koebner
Through study completion, estimated to 12 months.
Variation in Trauma induced Deep-Koebner
Through study completion, estimated to 12 months.
Other Outcomes (3)
Worsening of psoriasis due to scratching
Through study completion, estimated to 12 months.
Variation in worsening of psoriasis due to scratching over time
Through study completion, estimated to 12 months.
Presence of symptoms that could imply presence of psoriatic arthritis.
Through study completion, estimated to 12 months.
Study Arms (4)
PSODEEP1 Sweden
Patients with self reported MD given diagnosis of psoriasis and/or psoriatic arthritis in Sweden.
PSODEEP1 Denmark
Patients with self reported MD given diagnosis of psoriasis and/or psoriatic arthritis in Denmark.
PSODEEP1 Chile
Patients with self reported MD given diagnosis of psoriasis and/or psoriatic arthritis in Chile.
PSODEEP1 Netherlands
Patients with self reported MD given diagnosis of psoriasis and/or psoriatic arthritis in the Netherlands.
Eligibility Criteria
Adult patients with psoriasis and/or psoriatic arthritis
You may qualify if:
- MD diagnosis of psoriasis and/or psoriasis arthritis
- Age over 18 years
- Ability to read and understand written questions
- Having/ability to use smartphone
- Given consent
You may not qualify if:
- \- Having participated previously
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Skane University Hospitallead
- University of Chilecollaborator
- University of Copenhagencollaborator
- Karolinska Institutetcollaborator
- Lund Universitycollaborator
Study Sites (1)
Hudkliniken Skånes Universitetssjukhus
Malmo, Skåne County, 20502, Sweden
Related Publications (3)
Weiss G, Shemer A, Trau H. The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol. 2002 May;16(3):241-8. doi: 10.1046/j.1473-2165.2002.00406.x.
PMID: 12195563BACKGROUNDSoltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010 Jul;146(7):721-6. doi: 10.1001/archdermatol.2010.141.
PMID: 20644032BACKGROUNDPattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis. 2008 May;67(5):672-6. doi: 10.1136/ard.2007.073932. Epub 2007 Sep 6.
PMID: 17823200BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Albert Duvetorp, MD PhD
Lunds University, Copenhagen University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Head of Psoriasis outpatient clinic Malmö, MD PhD
Study Record Dates
First Submitted
October 15, 2022
First Posted
October 21, 2022
Study Start
October 19, 2022
Primary Completion
February 14, 2024
Study Completion
February 14, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12